Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
48
TRUMY Quote, Financials, Valuation and Earnings
Last price:
$18.14
Seasonality move
:
7.45%
Day range:
$17.43 - $18.24
52-week range:
$14.06 - $21.22
Dividend yield:
0.86%
P/E ratio:
34.52x
P/S ratio:
3.90x
P/B ratio:
2.93x
Volume:
71.5K
Avg. volume:
95K
1-year change:
8.38%
Market cap:
$26.8B
Revenue:
$6.8B
EPS (TTM):
$0.53
Earnings Data
Next earnings date for TRUMY
Aug 29
2025
Most recent earnings per share
$0.16
Beat by $0.16
(Dec 31/2024)
Consensus Estimate
--
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TRUMY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | -- | $1.7B | $0.16 | -- | -- |
| 06/30/2024 | Q2 | -- | $1.7B | $0.15 | -- | -- |
| 03/31/2024 | Q1 | -- | $1.6B | $0.12 | -- | -- |
| 12/31/2023 | Q4 | -- | $1.6B | $0.14 | -- | -- |
| 09/30/2023 | Q3 | -- | $1.6B | $0.13 | -- | -- |
| 06/30/2023 | Q2 | -- | $1.6B | $0.11 | -- | -- |
| 03/31/2023 | Q1 | -- | $1.5B | $0.10 | -- | -- |
| 12/31/2022 | Q4 | -- | $1.5B | $0.14 | -- | -- |
| 09/30/2022 | Q3 | -- | $1.5B | $0.09 | -- | -- |
| 06/30/2022 | Q2 | -- | $1.5B | $0.11 | -- | -- |
| 03/31/2022 | Q1 | -- | $1.5B | $0.10 | -- | -- |
| 12/31/2021 | Q4 | -- | $1.6B | $0.13 | -- | -- |
| 09/30/2021 | Q3 | -- | $1.6B | $0.13 | -- | -- |
| 06/30/2021 | Q2 | -- | $1.6B | $0.17 | -- | -- |
| 03/31/2021 | Q1 | -- | $1.6B | $0.12 | -- | -- |
| 12/31/2020 | Q4 | -- | $1.6B | $0.17 | -- | -- |
| 09/30/2020 | Q3 | -- | $1.4B | $0.11 | -- | -- |
| 06/30/2020 | Q2 | -- | $1.2B | $0.09 | -- | -- |
| 03/31/2020 | Q1 | -- | $1.5B | $0.11 | -- | -- |
| 12/31/2019 | Q4 | -- | $1.5B | $0.13 | -- | -- |
| 09/30/2019 | Q3 | -- | $1.4B | $0.14 | -- | -- |
| 06/30/2019 | Q2 | -- | $1.4B | $0.14 | -- | -- |
| 03/31/2019 | Q1 | -- | $1.4B | $0.14 | -- | -- |
| 12/31/2018 | Q4 | -- | $1.4B | $0.13 | -- | -- |
| 09/30/2018 | Q3 | -- | $1.3B | $0.10 | -- | -- |
| 06/30/2018 | Q2 | -- | $1.3B | $0.11 | -- | -- |
| 03/31/2018 | Q1 | -- | $1.4B | $0.09 | -- | -- |
| 12/31/2017 | Q4 | -- | $1.3B | $0.21 | -- | -- |
| 09/30/2017 | Q3 | -- | $1.3B | $0.12 | -- | -- |
| 06/30/2017 | Q2 | -- | $1.3B | $0.12 | -- | -- |
| 03/31/2017 | Q1 | -- | $1.2B | $0.13 | -- | -- |
| 12/31/2016 | Q4 | -- | $1.2B | $0.07 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.2B | $0.06 | -- | -- |
| 06/30/2016 | Q2 | -- | $1.2B | $0.06 | -- | -- |
| 03/31/2016 | Q1 | -- | $1.1B | $0.04 | -- | -- |
| 12/31/2015 | Q4 | -- | $1.1B | $0.08 | -- | -- |
| 09/30/2015 | Q3 | -- | $1.1B | $0.06 | -- | -- |
| 06/30/2015 | Q2 | -- | $1.1B | $0.07 | -- | -- |
Terumo Earnings Questions
-
How Much did Terumo Generate in Revenue Last Quarter?
Terumo reported $1.7B worth of top line sales in its most recent quarter.
-
Did Terumo Beat Earnings Last Quarter?
Terumo announced earnings per share of $0.16 which represents a beat of analyst forecast a -- per share.
-
Is Terumo Profitable?
Terumo reported $951.4M that represents $0.64 per share over the last quarter.
-
What is the Analyst Consensus for Terumo EPS Next Year?
Terumo's earnings are forecast to grow from $0.52 per share to -- per share next year representing an increase of --.
-
When is Terumo's Earnings Date?
Terumo's next earnings date is August 29, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 5
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
